Early Access

10-QPeriod: Q1 FY2010

ORACLE CORP Quarterly Report for Q1 Ended Aug 31, 2009

Filed September 21, 2009For Securities:ORCL

Summary

Oracle Corporation's Form 10-Q for the period ending August 31, 2009, highlights a period of revenue contraction offset by improved operating efficiency. Total revenues decreased by 5% year-over-year to $5.05 billion, primarily driven by a 14% decline in new software license revenues, even on a constant currency basis. However, software license updates and product support revenue saw a modest increase of 6% (11% constant currency), indicating strong customer retention. Total operating expenses decreased by 13% (9% constant currency), leading to a significant increase in operating income by 14% to $1.74 billion and a higher operating margin of 34%. The company also saw a substantial increase in cash and cash equivalents, bolstered by a $4.5 billion senior note issuance. The proposed $7.4 billion acquisition of Sun Microsystems remained a key strategic focus, pending regulatory approval.

Financial Statements
Beta
Revenue$5.05B
Cost of Revenue$0
Gross Profit$5.05B
Operating Expenses$3.31B
Operating Income$1.74B
Interest Expense$179.00M
Net Income$1.12B
EPS (Basic)$0.22
EPS (Diluted)$0.22
Shares Outstanding (Basic)5.01B
Shares Outstanding (Diluted)5.06B

Key Highlights

  • 1Total revenues declined 5% to $5.05 billion, with new software license revenue down 17% (14% constant currency).
  • 2Software license updates and product support revenue increased 6% to $3.12 billion (11% constant currency), showcasing strong customer retention.
  • 3Operating expenses decreased by 13% to $3.31 billion, leading to a 14% increase in operating income to $1.74 billion and a higher operating margin of 34%.
  • 4The company issued $4.5 billion in senior notes in July 2009, contributing to a significant increase in cash and cash equivalents to $16.1 billion.
  • 5Cash flow from operations improved by 15% to $3.74 billion.
  • 6The proposed acquisition of Sun Microsystems for approximately $7.4 billion was a key strategic development, awaiting regulatory clearance.
  • 7Earnings per share (diluted) remained steady at $0.22 for both periods, indicating effective cost management despite revenue pressures.

Frequently Asked Questions